A Phase I Study of Methoxyamine and Temozolomide in Patients With Advanced Solid Tumours
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2017
At a glance
- Drugs TRC 102 (Primary) ; Temozolomide
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 26 Jul 2017 Status changed from active, no longer recruiting to completed.
- 18 May 2017 According to a Tracon Pharmaceuticals media release, data from expanded cohorts of this trial will be presented by the National Cancer Institute at ASCO in June 2017.
- 28 Feb 2017 According to a Tracon Pharmaceuticals media release, presentation of data from expanded cohorts of this trial expected in 2017.